[1]王佳卉,马增香.多囊卵巢综合征及其并发症的直接经济负担研究进展[J].卫生经济研究,2022,39(3):24-27.
　WANG Jia-hui,MA Zeng-xiang.Research Progress on Direct Economic Burden of Polycystic Ovary Syndrome and Its Complications[J].Journal Press of Health Economics Research,2022,39(3):24-27.
点击复制

多囊卵巢综合征及其并发症的直接经济负担研究进展
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
39
期数:
2022年3期
页码:
24-27
栏目:
疾病经济负担
出版日期:
2022-03-01

文章信息/Info

Title:
Research Progress on Direct Economic Burden of Polycystic Ovary Syndrome and Its Complications
作者:
王佳卉1; 2; 马增香2
1.山东大学齐鲁医学院，山东 济南 250012
2.山东大学附属生殖医院，山东 济南 250021
Author(s):
WANG Jia-hui;  MA Zeng-xiang
Cheeloo College of Medicine, Shangdong University, Jinan Shangdong 250012, China
关键词:
多囊卵巢综合征; 并发症; 疾病经济负担
Keywords:
polycystic ovary syndrome (PCOS);  complication;  disease economic burden
分类号:
R19
文献标志码:
A
摘要:
多囊卵巢综合征是生育期女性最常见的内分泌代谢疾病，临床表现复杂，诊疗周期长，常合并糖尿病、异常子宫出血、不孕症、高雄激素表现等并发症，患者直接经济负担较重。当前，我国对多囊卵巢综合征的疾病负担研究尚处于起步阶段，以合并不孕症的研究为主，缺乏全面系统的认识。对此，本文总结相关研究进展，提出针对性建议，希望提高社会各界及育龄期女性对多囊卵巢综合征及其并发症的关注，从而加强科学有效的健康管理。
Abstract:
Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disease of childbearing age women. It has complex clinical manifestations and with long diagnosis and treatment cycles. PCOS has several complications, such as diabetes, abnormal uterine bleeding, infertility, and hyperandrogenism. The direct economic burden on patients is heavy. At present, the research on the disease burden of PCOS in our country is still in its infancy. The majority researches focused on infertility which reflects a lack of systematic understanding. In this regard, this paper summarized relevant research progress and put forward targeted suggestions, in order to call for more attention on PCOS and its complications and strengthen scientific and effective health management.

参考文献/References:

[1] JASON J.Polycystic ovary syndrome in the United States:Clinical visit rates,characteristics, and associated health care costs[J].Arch Intern Med,2011,171(13):1209-1211.
[2] OKOROH EM,HOOPER WC,ATRASH HK,etal.Prevalence of polycystic ovary syndrome among the privately insured,United States, 2003-2008[J].Am J Obstet Gyneco, 2012,207(4):299-297.
[3] HART R,DOHERTY DA.The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage.J Clin Endocrinol Metab,2015 Mar,100(3):911-919.
[4] LIU J,WU Q,HAO Y,et al.Measuring the global disease burden of polycystic ovary syndrome in 194 countries:Global Burden of Disease Study 2017[J].Hum Reprod,2021,36(4):1108-1119.
[5] AZZIZ R,MARIN C,HOQ L,et al.Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span[J].Clin Endocrinol Metab,2005,90(8):4650-4658.
[6] DIZON,MP,SCHMIDT TH,SHINKAI K,et al.High-value,cost-conscious evaluation for PCOS:Which tests should be routinely ordered in acne patients?[J].Cutis,2016,98(1):11-13.
[7] ALENZI EO.Cost-effectiveness analysis of polycystic ovary syndrome management and the risk of gestational diabetes in pregnant women:a decision-tree model[J].Expert Rev Pharmacoecon OutcomesRes,2020,24:1-5.
[8] AMIRI M,NAHIDI F,YARANDI RB,et al.Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome:a crossover randomized controlled trial[J].Health and Quality of Life Outcomes,2020,18(1):293.
[9] ALTINOK ML,RAVN P,ANDERSEN M,et al.Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome[J].Gynecol Endocrinol,2018,34(10):859-863.
[10] CINAR N,HARMANCI A,DEMIR B,et al.Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome:A prospective study[J].Hum Reprod, 2012,27(6):1840-1845.
[11] 刘真，翟所迪．多囊卵巢综合征患者2种促排卵治疗方案的决策树分析[J].中国药房，2012，23（2）：108-110.
[12] 刘真，唐惠林，翟所迪.来曲唑治疗多囊卵巢综合征的系统评价[J].中国药学杂志，2011，46 （22）：1762-1767.
[13] HU S,YU Q,WANG Y,et al.Letrozole versus clomiphene citrate in polycystic ovary syndrome:A meta-analysis of randomized controlled trials[J].Arch Gynecol Obstet,2018,297(5):1081-1088.
[14] KOVACS GT,CLARKE S,BURGER HG, et al.Surgical or medical treatment of polycystic ovary syndrome:A cost-benefit analysis[J].Gynecol Endocrinol,2002,16(1):53-55.
[15] 王力，闻姬，崔薇，等.不同促排卵方案在多囊卵巢综合征患者IVF-ET治疗中的应用分析[J].现代妇产科进展，2011，20 （4）：283-285，289.
[16] 刘博文，包淑婷，杨亦青，等.不同促排卵方案对多囊卵巢综合征患者IVF-ET妊娠结局的影响[J].生殖医学杂志, 2019（12）：1396-1401.
[17] 戴芳芳，郑波，郭钰英，等.多囊卵巢综合征患者不同促排卵方案助孕结局分析及经济评价[J].生殖医学杂志,2020，29 （9）：40-45.
[18] FRIDSTR?魻M M,SJ?魻BLOM P,GRANBERG M,et al.A cost comparison of infertility treatment for clomiphene resistant polycystic ovary syndrome [J].Acta Obstet Gynecol Scand,1999,78(3):212-216.
[19] FARQUHAR CM.An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate-resistant polycystic ovarian syndrome[J].Curr Opin Obstet Gynecol,2005,17(4)：347-353.
[20] De frène V,Gerris J,Weyers S,et al.Gonadotropin therapy versus laparoscopic ovarian drilling in clomiphene citrate-resistant polycystic ovary syndrome patients:A retrospective cost-effectiveness analysis[J].Gynecol Obstet Invest,2015,80(3)：164-169.
[21] DING T,HARDIMAN PJ,PETERSEN I,et al.Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome:A Bayesian modelling study[J].Hum Reprod, 2018,33(7):1299-1306.
[22] 林佳，蒋琪，石玉华.多囊卵巢综合征诊断分型及临床意义[J].中国实用妇科与产科杂志，2019，35（3）：267-271.

相似文献/References:

[1]姜德超,徐凤琴.基于R语言的DRGs分组方案中并发症与合并症分级方法研究[J].卫生经济研究,2019,(01):38.
　JIANG De-chao,XU Feng-qin.Research on Grading Methods of Complications and Comorbidities in DRGs Based on R Language[J].Journal Press of Health Economics Research,2019,(3):38.

更新日期/Last Update: 2022-03-01